Dose Response Study of a Topical Gel for the Treatment of Raynaud's Phenomenon

Clinical trial NCT00378521 · COMPLETED

Trial details

NCT number: NCT00378521
Sponsor: MediQuest Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Raynaud's Disease Raynaud's Disease Secondary to Scleroderma Raynaud's Disease Secondary to Autoimmune Disease

Start date: 2006-07-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.